PL Lodz Watala C: Difference between revisions

Revision as of 14:47, 1 July 2014

Mitochondrial respiratory capacity under normal and pathophysiological conditions (diabetes mellitus, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
Targeting of biochemical and molecular burden of diabetes

Everything what concerns OROBOROS company (oxygraphs, company staff, workshops, conferences, scientific discussions, the quality of information, etc.) works at the highest level !!!!!!! BRAVO for you :) - Magdalena Labieniec-Watala (2013)

Revision as of 14:46, 1 July 2014 (view source) Fleischmann Sandra (talk \| contribs) No edit summary ← Older edit		Revision as of 14:47, 1 July 2014 (view source) Fleischmann Sandra (talk \| contribs) No edit summary Newer edit →
Line 26:		Line 26:

	===Feedback===		===Feedback===
	* ''Everything what concerns OROBOROS company (oxygraphs, company staff, workshops, conferences, scientific discussions, the quality of information, etc.) works at the highest level !!!!!!! BRAVO for you :)'' - [[Labieniec-Watala M\|'''Magdalena Labieniec-Watala''']]		* ''Everything what concerns OROBOROS company (oxygraphs, company staff, workshops, conferences, scientific discussions, the quality of information, etc.) works at the highest level !!!!!!! BRAVO for you :)'' - [[Labieniec-Watala M\|'''Magdalena Labieniec-Watala''']] (2013)